IMMU Insider Trading Activity and SEC Form 4 Filings
IMMU insider trading summary
No open-market insider purchases or sales of Immunomedics Inc (IMMU) have been reported on SEC Form 4 in the past 12 months.
Latest IMMU insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 1, 2020 | Avoro Capital Advisors LLC | Director | Buy | $49.9M (1,750,000 @ $28.50) |
| May 1, 2020 | Behzad Aghazadeh | Director | Buy | $49.9M (1,750,000 @ $28.50) |
| Dec 5, 2019 | Avoro Capital Advisors LLC | Director | Buy | $35.0M (2,000,000 @ $17.50) |
| Dec 5, 2019 | Behzad Aghazadeh | Director | Buy | $35.0M (2,000,000 @ $17.50) |
| Oct 3, 2019 | Behzad Aghazadeh | Director | Buy | $7.0M (500,000 @ $14.10) |
| Oct 3, 2019 | Avoro Capital Advisors LLC | Director | Buy | $7.0M (500,000 @ $14.10) |
| Oct 3, 2019 | Bryan Ball | Chief Quality Officer | Buy | $71K (5,000 @ $14.18) |
| Oct 2, 2019 | Behzad Aghazadeh | Director | Buy | $13.2M (1,000,000 @ $13.23) |
| Oct 2, 2019 | Avoro Capital Advisors LLC | Director | Buy | $13.2M (1,000,000 @ $13.23) |
| Jun 28, 2019 | Avoro Capital Advisors LLC | Director | Buy | $3.5M (250,000 @ $13.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.